Last 48 quarters of trend data · Healthcare · Specialty & Generic Drugs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 13.15 | 12.12 | 10.89 | 20.81 | 22.96 | 22.44 | 24.22 | 29.19 | 31.58 | 32.56 | 31.64 | 32.29 | 43.28 | 33.72 | 29.69 | 34.97 | 37.01 | 32.81 | 38.37 | 37.42 | 70.12 |
| — | -46.0% | -55.0% | -28.7% | -27.3% | -31.1% | -23.5% | -9.6% | -27.0% | -3.4% | +6.5% | -7.6% | +17.0% | +2.8% | -22.6% | -6.6% | -47.2% | -21.6% | -11.9% | +11.2% | +27.1% | |
| P/S Ratio | 3.50 | 3.01 | 3.04 | 5.52 | 5.78 | 6.76 | 7.06 | 8.31 | 7.93 | 9.28 | 8.37 | 8.86 | 10.26 | 9.33 | 9.14 | 9.67 | 8.38 | 8.69 | 9.87 | 11.26 | 14.75 |
| — | -55.5% | -56.9% | -33.6% | -27.1% | -27.2% | -15.7% | -6.3% | -22.7% | -0.6% | -8.4% | -8.3% | +22.4% | +7.4% | -7.4% | -14.1% | -43.2% | -25.2% | -13.4% | +11.9% | +34.8% | |
| P/B Ratio | 10.58 | 8.70 | 9.53 | 15.44 | 16.57 | 12.01 | 13.96 | 15.85 | 15.41 | 16.93 | 15.94 | 15.37 | 18.19 | 15.82 | 17.25 | 17.22 | 15.54 | 14.92 | 17.70 | 19.20 | 25.54 |
| — | -27.6% | -31.7% | -2.5% | +7.5% | -29.0% | -12.4% | +3.1% | -15.3% | +7.0% | -7.6% | -10.8% | +17.1% | +6.0% | -2.5% | -10.3% | -39.2% | -24.5% | -13.4% | +4.4% | +21.8% | |
| P/FCF | 14.61 | 10.02 | 13.95 | 42.90 | 18.85 | 20.14 | 56.39 | 42.10 | 26.67 | 28.25 | 53.41 | 42.66 | 32.48 | 34.66 | 1172.29 | 59.30 | 30.00 | 46.75 | 106.64 | 115.22 | 56.78 |
| — | -50.2% | -75.3% | +1.9% | -29.3% | -28.7% | +5.6% | -1.3% | -17.9% | -18.5% | -95.4% | -28.1% | +8.2% | -25.9% | +999.3% | -48.5% | -47.2% | +8.0% | +76.6% | +97.8% | +64.8% | |
| EV / EBITDA | 10.31 | 9.33 | 8.94 | 15.20 | 16.46 | 16.52 | 16.82 | 20.41 | 22.03 | 22.49 | 20.38 | 22.23 | 28.60 | 23.12 | 22.19 | 24.16 | 22.53 | 22.02 | 25.25 | 25.75 | 41.84 |
| — | -43.5% | -46.8% | -25.5% | -25.3% | -26.6% | -17.5% | -8.2% | -23.0% | -2.7% | -8.1% | -8.0% | +26.9% | +5.0% | -12.1% | -6.2% | -46.1% | -23.1% | -8.8% | +12.6% | +25.6% | |
| EV / EBIT | 11.25 | 11.58 | 10.19 | 17.45 | 19.06 | 18.53 | 19.49 | 22.67 | 24.83 | 25.04 | 24.98 | 25.47 | 33.68 | 27.33 | 22.66 | 26.79 | 27.66 | 25.49 | 29.28 | 29.70 | 52.98 |
| — | -37.5% | -47.7% | -23.0% | -23.2% | -26.0% | -22.0% | -11.0% | -26.3% | -8.4% | +10.2% | -4.9% | +21.8% | +7.2% | -22.6% | -9.8% | -47.8% | -23.7% | -12.0% | +12.3% | +23.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.5% | 70.8% | 72.7% | 71.7% | 68.9% | 70.2% | 72.3% | 70.5% | 68.0% | 69.2% | 70.2% | 68.9% | 65.4% | 68.6% | 70.5% | 68.8% | 66.3% | 67.8% | 67.7% | 69.3% | 67.5% |
| — | +0.9% | +0.6% | +1.6% | +1.3% | +1.5% | +2.9% | +2.3% | +4.0% | +0.9% | -0.3% | +0.3% | -1.3% | +1.1% | +4.0% | -0.8% | -1.8% | -1.0% | -1.5% | +1.1% | +4.6% | |
| Operating Margin | 38.0% | 36.1% | 38.0% | 36.3% | 34.6% | 39.0% | 40.2% | 38.1% | 33.0% | 38.5% | 38.4% | 36.6% | 32.0% | 37.1% | 38.3% | 36.4% | 33.8% | 36.1% | 35.4% | 39.7% | 30.3% |
| — | -7.5% | -5.6% | -4.6% | +4.8% | +1.2% | +4.8% | +4.2% | +3.1% | +3.8% | +0.3% | +0.5% | -5.3% | +2.7% | +8.1% | -8.4% | +11.6% | -1.3% | -4.8% | -1.5% | +6.7% | |
| Net Margin | 28.2% | 24.7% | 28.0% | 26.6% | 25.3% | 30.0% | 29.2% | 28.4% | 25.1% | 28.6% | 26.4% | 27.4% | 23.7% | 27.7% | 30.8% | 27.6% | 22.6% | 26.4% | 25.8% | 30.0% | 21.0% |
| — | -17.7% | -4.1% | -6.5% | +0.7% | +5.2% | +10.4% | +3.9% | +5.7% | +3.1% | -14.1% | -0.9% | +5.0% | +4.9% | +19.4% | -7.9% | +7.4% | -4.7% | -1.9% | +0.3% | +5.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 66.0% | 18.3% | 21.7% | 18.3% | 13.8% | 13.9% | 14.9% | 13.4% | 11.6% | 13.4% | 12.5% | 11.9% | 10.4% | 12.3% | 14.7% | 12.4% | 10.2% | 11.4% | 11.5% | 12.9% | 9.0% |
| — | +31.8% | +45.3% | +36.8% | +18.9% | +3.9% | +19.6% | +12.2% | +11.3% | +8.8% | -15.4% | -3.9% | +2.6% | +7.4% | +28.6% | -4.0% | +13.3% | -6.3% | -5.6% | -9.0% | -7.7% | |
| ROA | 18.0% | 3.9% | 4.6% | 3.9% | 3.9% | 4.9% | 5.0% | 4.5% | 4.1% | 4.8% | 4.4% | 4.2% | 3.7% | 4.3% | 4.9% | 3.8% | 3.2% | 3.9% | 3.8% | 4.3% | 3.0% |
| — | -19.5% | -9.0% | -11.9% | -3.1% | +1.7% | +14.8% | +6.5% | +9.9% | +11.8% | -10.3% | +8.7% | +14.7% | +11.0% | +27.4% | -10.2% | +7.5% | -3.0% | +4.2% | +5.1% | +14.2% | |
| ROIC | 26.9% | 5.9% | 6.6% | 5.9% | 5.9% | 6.7% | 7.4% | 6.6% | 5.8% | 6.8% | 6.8% | 6.1% | 5.4% | 6.1% | 6.7% | 6.1% | 5.8% | 6.2% | 6.4% | 7.4% | 5.6% |
| — | -12.8% | -11.6% | -11.3% | +1.4% | -0.7% | +9.0% | +7.5% | +7.7% | +11.4% | +2.1% | +1.5% | -7.4% | -1.6% | +3.5% | -17.9% | +3.7% | -8.5% | -5.9% | +0.0% | +11.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 2.85 | 2.80 | 2.93 | 2.86 | 2.85 | 1.35 | 1.36 | 1.45 | 1.41 | 1.29 | 1.36 | 1.34 | 1.35 | 1.33 | 1.46 | 1.50 | 1.84 | 1.45 | 1.47 | 1.45 | 1.48 |
| — | +107.6% | +115.1% | +97.1% | +101.6% | +4.4% | +0.4% | +8.2% | +4.5% | -2.9% | -6.8% | -10.7% | -26.3% | -8.2% | -0.7% | +3.8% | +23.8% | +0.4% | -12.9% | -19.5% | -23.9% | |
| Debt / EBITDA | 2.32 | 9.41 | 8.75 | 9.82 | 10.02 | 6.86 | 6.11 | 6.99 | 7.59 | 6.49 | 6.53 | 7.30 | 8.09 | 7.32 | 7.06 | 7.95 | 10.00 | 8.05 | 7.99 | 7.46 | 9.46 |
| — | +37.1% | +43.2% | +40.3% | +32.0% | +5.7% | -6.5% | -4.2% | -6.1% | -11.3% | -7.6% | -8.1% | -19.1% | -9.2% | -11.6% | +6.6% | +5.7% | -0.0% | -9.1% | -12.3% | -20.1% | |
| Current Ratio | 3.03 | 2.35 | 3.08 | 3.15 | 3.03 | 3.64 | 1.76 | 1.74 | 1.75 | 3.69 | 3.45 | 3.33 | 3.36 | 3.87 | 3.50 | 3.27 | 2.37 | 2.27 | 2.18 | 2.25 | 3.86 |
| — | -35.6% | +75.3% | +81.6% | +72.6% | -1.3% | -49.0% | -47.9% | -47.8% | -4.6% | -1.3% | +1.8% | +41.7% | +70.1% | +60.3% | +45.3% | -38.5% | -49.9% | -35.3% | -31.5% | +26.6% | |
| Quick Ratio | 1.94 | 1.40 | 1.84 | 1.91 | 1.94 | 2.28 | 1.04 | 1.04 | 1.08 | 2.27 | 2.09 | 1.94 | 2.00 | 2.16 | 1.97 | 1.94 | 1.63 | 1.48 | 1.46 | 1.58 | 2.79 |
| — | -38.5% | +77.3% | +84.2% | +80.0% | +0.3% | -50.4% | -46.6% | -46.1% | +5.0% | +6.0% | +0.4% | +22.8% | +46.6% | +35.1% | +22.8% | -41.5% | -54.9% | -41.9% | -36.1% | +21.3% | |
| Interest Coverage | 14.74 | 12.76 | 15.20 | 13.23 | 14.35 | 14.77 | 16.55 | 14.73 | 14.07 | 15.33 | 13.38 | 13.05 | 12.02 | 12.38 | 14.84 | 11.25 | 9.84 | 12.70 | 12.75 | 13.98 | 9.88 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ZTS stock.
Zoetis Inc.'s current P/E is 13.1x. The average P/E over the last 4 quarters is 16.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Zoetis Inc.'s current operating margin is 38.0%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Zoetis Inc.'s business trajectory between earnings reports.